KR20200142521A - Pedf-유래 짧은 펩타이드의 힘줄 치유에의 적용 - Google Patents

Pedf-유래 짧은 펩타이드의 힘줄 치유에의 적용 Download PDF

Info

Publication number
KR20200142521A
KR20200142521A KR1020207031085A KR20207031085A KR20200142521A KR 20200142521 A KR20200142521 A KR 20200142521A KR 1020207031085 A KR1020207031085 A KR 1020207031085A KR 20207031085 A KR20207031085 A KR 20207031085A KR 20200142521 A KR20200142521 A KR 20200142521A
Authority
KR
South Korea
Prior art keywords
xaa
amino acid
misc
feature
naturally occurring
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Ceased
Application number
KR1020207031085A
Other languages
English (en)
Korean (ko)
Inventor
프랭크 웬-치 리
유안-밍 리
여우-핑 차오
충-추안 호
Original Assignee
브림 바이오테크놀로지, 인코퍼레이티드
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by 브림 바이오테크놀로지, 인코퍼레이티드 filed Critical 브림 바이오테크놀로지, 인코퍼레이티드
Publication of KR20200142521A publication Critical patent/KR20200142521A/ko
Ceased legal-status Critical Current

Links

Images

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/04—Peptides having up to 20 amino acids in a fully defined sequence; Derivatives thereof
    • A61K38/10—Peptides having 12 to 20 amino acids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0019—Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A61P19/04—Drugs for skeletal disorders for non-specific disorders of the connective tissue

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Medicinal Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Epidemiology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Immunology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Biomedical Technology (AREA)
  • Dermatology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Peptides Or Proteins (AREA)
KR1020207031085A 2018-04-08 2019-04-08 Pedf-유래 짧은 펩타이드의 힘줄 치유에의 적용 Ceased KR20200142521A (ko)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US201862654466P 2018-04-08 2018-04-08
US62/654,466 2018-04-08
PCT/US2019/026307 WO2019199661A1 (en) 2018-04-08 2019-04-08 Application of pedf-derived short peptides in tendon healing

Publications (1)

Publication Number Publication Date
KR20200142521A true KR20200142521A (ko) 2020-12-22

Family

ID=68163751

Family Applications (1)

Application Number Title Priority Date Filing Date
KR1020207031085A Ceased KR20200142521A (ko) 2018-04-08 2019-04-08 Pedf-유래 짧은 펩타이드의 힘줄 치유에의 적용

Country Status (10)

Country Link
US (1) US20210244791A1 (cg-RX-API-DMAC7.html)
EP (1) EP3761959A4 (cg-RX-API-DMAC7.html)
JP (2) JP7481261B2 (cg-RX-API-DMAC7.html)
KR (1) KR20200142521A (cg-RX-API-DMAC7.html)
CN (1) CN113038929A (cg-RX-API-DMAC7.html)
AU (2) AU2019251091A1 (cg-RX-API-DMAC7.html)
EA (1) EA202092368A1 (cg-RX-API-DMAC7.html)
IL (1) IL277689B2 (cg-RX-API-DMAC7.html)
TW (1) TWI902659B (cg-RX-API-DMAC7.html)
WO (1) WO2019199661A1 (cg-RX-API-DMAC7.html)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20210244791A1 (en) * 2018-04-08 2021-08-12 Brim Biotechnology, Inc. Application of pedf-derived short peptides in tendon healing

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP1924276A4 (en) * 2005-08-05 2009-07-22 Araim Pharmaceuticals Inc Antiperspirant peptides and their uses
EP1986676A4 (en) * 2006-02-15 2009-11-04 Univ Yale Inc COMPOSITIONS AND METHODS FOR USE OF PEDF (PIGMENT-BASED EPITHELIC DERIVED FACTOR) PEPTIDE FRAGMENTS
ES2329636B2 (es) * 2006-02-17 2010-07-26 Universitat De Valencia, Estudi General (Participa Con El 70%) Uso del factor pedf para inducir la auto-renovacion de celulas madre.
EP2508196B1 (en) * 2011-03-23 2018-09-26 Mackay Memorial Hospital Use of PEDF-derived polypeptides for promoting stem cells proliferation and wound healing
AU2012387503B2 (en) * 2012-08-09 2016-11-03 Mackay Memorial Hospital Use of PEDF-derived polypeptides for promoting muscle or tendon regeneration or arteriogenesis
TWI491616B (zh) * 2012-08-09 2015-07-11 Mackay Memorial Hospital 色素上皮衍生因子衍生之多胜肽於促進肌肉或肌腱再生或動脈血管生成之用途
KR20230169375A (ko) * 2016-10-07 2023-12-15 브림 바이오테크놀로지, 인코퍼레이티드 Pedf-유래 짧은 펩타이드를 포함하는 조성물 및 그것의 사용
US20210244791A1 (en) * 2018-04-08 2021-08-12 Brim Biotechnology, Inc. Application of pedf-derived short peptides in tendon healing

Also Published As

Publication number Publication date
IL277689B1 (en) 2024-08-01
AU2019251091A1 (en) 2020-11-26
TW202010513A (zh) 2020-03-16
JP7481261B2 (ja) 2024-05-10
CN113038929A (zh) 2021-06-25
TWI902659B (zh) 2025-11-01
IL277689A (en) 2020-11-30
IL277689B2 (en) 2024-12-01
EA202092368A1 (ru) 2021-01-18
AU2025201569A1 (en) 2025-05-22
US20210244791A1 (en) 2021-08-12
JP2024054273A (ja) 2024-04-16
EP3761959A4 (en) 2022-03-02
WO2019199661A1 (en) 2019-10-17
EP3761959A1 (en) 2021-01-13
JP2021521113A (ja) 2021-08-26

Similar Documents

Publication Publication Date Title
JP5579445B2 (ja) 軟骨形成を促進するペプチド組成物および方法
Nazareth et al. Differing phagocytic capacities of accessory and main olfactory ensheathing cells and the implication for olfactory glia transplantation therapies
EP2882772B1 (en) Use of pedf-derived polypeptides for promoting muscle or tendon regeneration or arteriogenesis
BR112015021269B1 (pt) Polipeptídeo isolado, seu uso e composição farmacêutica
BR112012031587B1 (pt) Composição compreendendo um peptídeo e pelo menos um outro componente farmaceuticamente aceitável para o tratamento ou prevenção de dano de cartilagem e artrite
Ho et al. PEDF-derived peptide promotes tendon regeneration through its mitogenic effect on tendon stem/progenitor cells
Barbon et al. In vitro assessment of TAT—Ciliary Neurotrophic Factor therapeutic potential for peripheral nerve regeneration
Ashraf et al. RHEB gene therapy maintains the chondrogenic characteristics and protects cartilage tissue from degenerative damage during experimental murine osteoarthritis
Qiu et al. Bone marrow mesenchymal stem cells overexpressing FGF-2 loaded onto a decellularized extracellular matrix hydrogel for the treatment of osteoarthritis
JP2024054273A (ja) 腱治癒に対するpedf由来短鎖ペプチドの使用
US10434135B2 (en) Pharmaceutical composition for preventing or treating arthritis
WO2008019434A1 (en) The use of growth factors in a method of improving fat-graft survival
JP7863335B2 (ja) 細胞外マトリックスに結合するIL-1受容体アンタゴニスト(IL-1Ra)融合タンパク質
JP2017538683A (ja) 抗血管形成薬としてのオリゴペプチド体
KR19990082999A (ko) 연골 유도를 위한 골유도 단백질과 배화 인자의 조합물의 용도
JP2024046128A (ja) 骨形成促進剤
Benissan-Messan MG53 improves regeneration of satellite cells and healing following volumetric muscle loss injury by decreasing fibrosis and modulating the inflammatory environment
Johnstone The Influence of Neurotrophins on Traumatic Brain Injury, Fracture Healing and Bone Metabolism
Ho et al. Articles in PresS. Am J Physiol Cell Physiol (June 3, 2015). doi: 10.1152/ajpcell. 00344.2014
WO2021097538A1 (en) Bone formation
Yang Tendon extracellular matrix: Tenogenic activity on mesenchymal stem cells and utility in tendon tissue engineering

Legal Events

Date Code Title Description
PA0105 International application

St.27 status event code: A-0-1-A10-A15-nap-PA0105

PG1501 Laying open of application

St.27 status event code: A-1-1-Q10-Q12-nap-PG1501

A201 Request for examination
PA0201 Request for examination

St.27 status event code: A-1-2-D10-D11-exm-PA0201

E902 Notification of reason for refusal
PE0902 Notice of grounds for rejection

St.27 status event code: A-1-2-D10-D21-exm-PE0902

T11-X000 Administrative time limit extension requested

St.27 status event code: U-3-3-T10-T11-oth-X000

T11-X000 Administrative time limit extension requested

St.27 status event code: U-3-3-T10-T11-oth-X000

T11-X000 Administrative time limit extension requested

St.27 status event code: U-3-3-T10-T11-oth-X000

T11-X000 Administrative time limit extension requested

St.27 status event code: U-3-3-T10-T11-oth-X000

E13-X000 Pre-grant limitation requested

St.27 status event code: A-2-3-E10-E13-lim-X000

P11-X000 Amendment of application requested

St.27 status event code: A-2-2-P10-P11-nap-X000

B15 Application refused following examination

Free format text: ST27 STATUS EVENT CODE: N-2-6-B10-B15-EXM-PE0601 (AS PROVIDED BY THE NATIONAL OFFICE)

PE0601 Decision on rejection of patent

St.27 status event code: N-2-6-B10-B15-exm-PE0601

T11 Administrative time limit extension requested

Free format text: ST27 STATUS EVENT CODE: U-3-3-T10-T11-OTH-X000 (AS PROVIDED BY THE NATIONAL OFFICE)

T11-X000 Administrative time limit extension requested

St.27 status event code: U-3-3-T10-T11-oth-X000

T13 Administrative time limit extension granted

Free format text: ST27 STATUS EVENT CODE: U-3-3-T10-T13-OTH-X000 (AS PROVIDED BY THE NATIONAL OFFICE)

T13-X000 Administrative time limit extension granted

St.27 status event code: U-3-3-T10-T13-oth-X000

T11 Administrative time limit extension requested

Free format text: ST27 STATUS EVENT CODE: U-3-3-T10-T11-OTH-X000 (AS PROVIDED BY THE NATIONAL OFFICE)

T11-X000 Administrative time limit extension requested

St.27 status event code: U-3-3-T10-T11-oth-X000

T13 Administrative time limit extension granted

Free format text: ST27 STATUS EVENT CODE: U-3-3-T10-T13-OTH-X000 (AS PROVIDED BY THE NATIONAL OFFICE)

T13-X000 Administrative time limit extension granted

St.27 status event code: U-3-3-T10-T13-oth-X000

E13 Pre-grant limitation requested

Free format text: ST27 STATUS EVENT CODE: A-2-3-E10-E13-LIM-X000 (AS PROVIDED BY THE NATIONAL OFFICE)

E13-X000 Pre-grant limitation requested

St.27 status event code: A-2-3-E10-E13-lim-X000

P11 Amendment of application requested

Free format text: ST27 STATUS EVENT CODE: A-2-2-P10-P11-NAP-X000 (AS PROVIDED BY THE NATIONAL OFFICE)

P11-X000 Amendment of application requested

St.27 status event code: A-2-2-P10-P11-nap-X000

B17 Application discontinued following pre-grant review

Free format text: ST27 STATUS EVENT CODE: N-2-6-B10-B17-REX-PX0601 (AS PROVIDED BY THE NATIONAL OFFICE)

PX0601 Decision of rejection after re-examination

St.27 status event code: N-2-6-B10-B17-rex-PX0601